Earlier quoted context omitted.
> Hasn't this been fixed with the requirement to pre-register trials? If it was that simple... Preregistration is a step in the right direction, but there are still plenty of ways to game the system, particularly as it's not properly enforced: http://compare-trials.org/
But it is the necessary step to highlight the problem so that actions can be taken. Also, you can safely assume that the large majority of outcomes that were not published were:\ - negative - worse than negative (i.e. safety issues?) - not properly designed So if you compare the number of trials disclosed/not disclosed for each drug/each company that gives you a pretty good picture of who is doing what already. With…
Be a drug company. Develop a "drug" that is really a placebo (has no effect). Do 10 trials. 8 are "no effect", 1 is positive (by chance), 1 is negative (by cance). Publish the positive drug. Market the drug as having positive effect. Sell the drug, make billions. It would take decades for enough other research (mostly "no effect") to accumulate before it becomes obvious that your drug actually has no effect.